IRIS
MINUTO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.937
AS - Asia 1.619
NA - Nord America 539
SA - Sud America 119
AF - Africa 22
OC - Oceania 1
Totale 21.237
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.684
SG - Singapore 752
US - Stati Uniti d'America 501
CN - Cina 407
VN - Vietnam 298
FR - Francia 124
BR - Brasile 74
HK - Hong Kong 48
FI - Finlandia 34
JP - Giappone 25
DE - Germania 23
MX - Messico 21
AR - Argentina 20
GB - Regno Unito 18
CH - Svizzera 15
BD - Bangladesh 13
IQ - Iraq 13
ID - Indonesia 12
CA - Canada 11
EC - Ecuador 10
IE - Irlanda 10
SA - Arabia Saudita 6
CL - Cile 5
IN - India 5
NL - Olanda 5
PH - Filippine 5
UA - Ucraina 5
VE - Venezuela 5
ZA - Sudafrica 5
RU - Federazione Russa 4
TH - Thailandia 4
AZ - Azerbaigian 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
SE - Svezia 3
TN - Tunisia 3
UZ - Uzbekistan 3
BY - Bielorussia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
ES - Italia 2
ET - Etiopia 2
MY - Malesia 2
PE - Perù 2
PK - Pakistan 2
PS - Palestinian Territory 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
LB - Libano 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
TG - Togo 1
TW - Taiwan 1
VI - Stati Uniti Isole Vergini 1
Totale 21.237
Salva come PNG Salva come JPEG
Città #
Genova 12.220
Genoa 3.733
Rapallo 1.625
Vado Ligure 1.056
Singapore 359
San Jose 268
Lauterbourg 123
Ho Chi Minh City 98
Beijing 70
Hanoi 57
Ashburn 47
Hong Kong 47
Helsinki 34
New York 32
Santa Clara 25
Tokyo 24
Frankfurt am Main 22
Bordighera 20
Haiphong 18
Zurich 15
Da Nang 12
Orem 11
Dublin 10
São Paulo 10
Tianjin 10
Mexico City 9
Cardiff 6
City of London 6
Guayaquil 6
Biên Hòa 5
Chicago 5
Thái Bình 5
Baghdad 4
Council Bluffs 4
Los Angeles 4
Montreal 4
Rome 4
Shanghai 4
Toronto 4
Amsterdam 3
Buffalo 3
Bắc Ninh 3
Can Tho 3
Guangzhou 3
Huế 3
Hải Dương 3
Joinville 3
Kyiv 3
Manchester 3
Nairobi 3
Ninh Bình 3
Riyadh 3
Surabaya 3
Tashkent 3
Addis Ababa 2
Amman 2
Atlanta 2
Baku 2
Bangkok 2
Brooklyn 2
Campinas 2
Cape Town 2
Coro 2
Des Moines 2
Imus 2
Jakarta 2
Johannesburg 2
Lima 2
London 2
Madrid 2
Milan 2
Nha Trang 2
Phủ Lý 2
Reconquista 2
Ribeirão Preto 2
Rio de Janeiro 2
Santiago 2
Stockholm 2
Tunis 2
Turin 2
Abidjan 1
Agawam 1
Algiers 1
Ambato 1
Ancona 1
Andaraí 1
Angeles City 1
Aquidabã 1
Arica 1
Bamako 1
Barquisimeto 1
Beirut 1
Belén de Escobar 1
Benito Juarez 1
Benque Viejo el Carmen 1
Bensalem 1
Berezne 1
Bogotá 1
Bologna 1
Brasília 1
Totale 20.133
Salva come PNG Salva come JPEG
Nome #
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 222
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 220
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 209
Acromegaly is associated with increased cancer risk: A survey in Italy 209
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 208
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 208
Pituitary image: pituicytoma. 198
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 197
Computed tomography colonography in acromegaly 194
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 191
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 189
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 189
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 188
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 187
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 185
Characterization of the IGF system in 15 patients with Alstrom syndrome. 184
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 183
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 183
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 183
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 180
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 178
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 178
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 178
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 177
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 177
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 176
The pathology of the ulnar nerve in acromegaly. 175
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 175
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 175
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 173
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 172
Indirect evidence of hormone abuse. Proof of doping? 168
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 168
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 166
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 166
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 164
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 164
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 162
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 161
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 160
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 160
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 159
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 159
Growth hormone secretion in pubertal and adult subjects. 158
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 157
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 156
Initial staging of lymphoma with octreotide and other receptor imaging agents. 156
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 156
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 156
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 156
Somatostatin receptor scintigraphy in thoracic diseases 155
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 155
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 154
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 154
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 153
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 153
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 153
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 152
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 151
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 151
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 150
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 149
Behaviour of typeII receptors of IGFs in different age and thyroid status in adult rat liver 149
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 147
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 146
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 146
Papillary thyroid cancer in a struma ovarii: a report of a rare case 146
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 145
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 144
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 144
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 143
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 143
Sympathovagal imbalance in acromegalic patients 142
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 142
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 142
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 142
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 141
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 141
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 138
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 138
Cost-of-illness study in acromegalic patients in Italy 137
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 137
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 136
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 135
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 134
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 134
Wireless connections in a hospital ward: the WARD-IN-HAND Project 133
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 133
Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy 132
Replacement therapy and cardiovascular diseases 132
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 132
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children 132
Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation 129
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 129
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case for 129
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 129
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 129
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 128
Sympathovagal imbalance in transsexual subjects. 127
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. 127
Totale 15.936
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.191
article - articoli 56.395
book - libri 0
conference - conferenze 2.643
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.153
Totale 120.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021281 0 0 0 0 0 0 0 0 0 116 77 88
2021/20221.863 35 97 168 233 72 128 134 434 89 174 58 241
2022/20231.937 177 143 37 227 310 351 3 130 303 5 226 25
2023/2024782 41 105 12 114 65 128 51 46 46 14 57 103
2024/20252.650 53 183 76 172 389 247 281 435 103 86 277 348
2025/20263.652 535 95 214 318 616 388 747 175 287 277 0 0
Totale 21.286